The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 03, 2026
Filed:
Jan. 20, 2026
Galvanize Therapeutics, Inc., Redwood City, CA (US);
Robert E. Neal, II, Redwood City, CA (US);
William S. Krimsky, Forest Hill, MD (US);
Seth S. Gleiman, Guillford, CT (US);
Nicholas S. Mercer, San Francisco, CA (US);
Timothy J. O'brien, Santa Clara, CA (US);
Quim Castellvi, Barcelona, ES;
Jonathan R. Waldstreicher, West Orange, NJ (US);
Kevin J. Taylor, San Mateo, CA (US);
Luis L. Mangual Arbelo, Sunnyvale, CA (US);
Chiara Pastori, Hayward, CA (US);
Ebtesam Nafie, Belmont, CA (US);
Mukta S. Wagh, Sunnyvale, CA (US);
Galvanize Therapeutics, Inc., Redwood City, CA (US);
Abstract
Devices, systems and methods are provided to treat damaged, diseased, abnormal, obstructive, cancerous or undesired tissue (e.g. a tumor, a benign tumor, a malignant tumor, a cyst, or an area of diseased tissue, etc) by delivering specialized pulsed electric field (PEF) energy to target tissue areas. The energy is delivered in a manner so as to be non-thermal (i.e. below a threshold for causing thermal ablation). Consequently, when extracellular matrices present, the extracellular matrices are preserved, and the targeted tissue maintains its structural architecture including blood vessels and lymphatics. Thus, sensitive structures, such as biological lumens, blood vessels, nerves, etc, are preserved which are critical to maintaining the integrity and functionality of the tissue. The energy is delivered with the use of systems and devices advantageously designed for superior access to target tissue throughout the body, particularly in locations previously considered inaccessible to percutaneous approaches.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile